However, CD8+ Teff functions and proliferation were diminished in co-cultures of FXR+PDL1- lung cancer cell lines, suggesting FXR as a biomarker for an immunosuppressive yet checkpoint-inhibitor-responsive tumor microenvironment. The gene discussed is CD8A; the disease is lung carcinoma.